Magnetic Resonance Imaging
Volume 28, Issue 4 , Pages 594-598 , May 2010

Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas

  • Masaaki Hori

      Affiliations

    • Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuou, Yamanashi, 409-3898, Japan
    • Department of Radiology, Toho University Omori Medical Center, 6-11-1, Omori-nishi, Ota, Tokyo, 143-8541, Japan
    • Department of Radiology, School of Medicine, Juntendo University, 2-1-1 Hongo, Tokyo, 113-8421, Japan
    • Corresponding Author InformationCorresponding author. Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuou, Yamanashi, 409-3898, Japan. Tel.: +81 55 273 1111x2382; fax: +81 55 273 6744.
    • ,
  • Harushi Mori

      Affiliations

    • Department of Radiology, University of Tokyo, 7-3-1, Hongo, Tokyo, 113-8655, Japan
    • ,
  • Shigeki Aoki

      Affiliations

    • Department of Radiology, School of Medicine, Juntendo University, 2-1-1 Hongo, Tokyo, 113-8421, Japan
    • ,
  • Osamu Abe

      Affiliations

    • Department of Radiology, University of Tokyo, 7-3-1, Hongo, Tokyo, 113-8655, Japan
    • ,
  • Tomohiko Masumoto

      Affiliations

    • Department of Radiology, Tsukuba University Hospital, 2-1-1, Amakubo, Tsukuba City, 305-8576, Japan
    • ,
  • Satoshi Kunimatsu

      Affiliations

    • Department of Radiology, University of Tokyo, 7-3-1, Hongo, Tokyo, 113-8655, Japan
    • ,
  • Kuni Ohtomo

      Affiliations

    • Department of Radiology, University of Tokyo, 7-3-1, Hongo, Tokyo, 113-8655, Japan
    • ,
  • Hiroyuki Kabasawa

      Affiliations

    • Department of Radiology, University of Tokyo, 7-3-1, Hongo, Tokyo, 113-8655, Japan
    • ,
  • Nobuyuki Shiraga

      Affiliations

    • Department of Radiology, Toho University Omori Medical Center, 6-11-1, Omori-nishi, Ota, Tokyo, 143-8541, Japan
    • ,
  • Tsutomu Araki

      Affiliations

    • Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuou, Yamanashi, 409-3898, Japan

Received 28 August 2009 ,Revised 4 November 2009 ,Accepted 5 January 2010.

References 

  1. Pouratian N, Asthagiri A, Jagannathan J, Shaffrey ME, Schiff D. Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol. 2007;3:628–639
  2. Schiff D, Brown PD, Giannini C. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology. 2007;69:1366–1373
  3. Norden AD, Wen PY. Glioma therapy in adults. Neurologist. 2006;12:279–292
  4. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006;24:1273–1280
  5. Schramm J, Blumcke I, Ostertag CB, Schlegel U, Simon M, Lutterbach J. Low-grade gliomas — current concepts. Zentralbl Neurochir. 2006;67:55–66
  6. Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology. 1997;202:511–516
  7. Recht L, Torres CO, Smith TW, Raso V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg. 1990;72:941–945
  8. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41–51
  9. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol. 2005;26:736–742
  10. Rauscher A, Sedlacik J, Fitzek C, Walter B, Hochstetter A, Kalff R, et al. High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent. Rofo. 2005;177:1065–1069
  11. Rauscher A, Sedlacik J, Deistung A, Mentzel HJ, Reichenbach JR. Susceptibility weighted imaging: data acquisition, image reconstruction and clinical applications. Z Med Phys. 2006;16:240–250
  12. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 2005;22:439–450
  13. Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging. 2006;24:41–51
  14. Reichenbach JR, Barth M, Haacke EM, Klarhöfer M, Kaiser WA, Moser E. High-resolution MR venography at 3.0 tesla. J Comput Assist Tomogr. 2000;24:949–957
  15. Noebauer-Huhmann IM, Pinker K, Barth M, Mlynarik V, Ba-Ssalamah A, Saringer WF, et al. Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers. Invest Radiol. 2006;41:249–255
  16. Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Karanikas G, et al. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol. 2007;28:1280–1286
  17. Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009;30:1574–1579
  18. Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Weber M, et al. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors. Neuroradiology. 2008;50:9–16
  19. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, Part 1. AJNR Am J Neuroradiol 2009;30:19–30.
  20. Lin W, Mukherjee P, An H, Yu Y, Wang Y, Vo K, et al. Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging. 1999;10:118–123
  21. Hori M, Ishigame K, Kabasawa H, Kumagai H, Ikenaga S, Shiraga N, Aoki S, Araki T. Pre- and postcontrast susceptibility weighted imaging in the assessment of intracranial brain neoplasms at 1.5T. Jpn J Radiol [in press].
  22. Thomas B, Somasundaram S, Thamburaj K, Kesavadas C, Gupta AK, Bodhey NK, et al. Clinical applications of susceptibility weighted MR imaging of the brain — a pictorial review. Neuroradiology. 2008;50:105–116
  23. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, Part 2. AJNR Am J Neuroradiol. 2009;30:232–252
  24. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–229
  25. Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30:1402–1408

PII: S0730-725X(10)00026-3

doi: 10.1016/j.mri.2010.01.002

Magnetic Resonance Imaging
Volume 28, Issue 4 , Pages 594-598 , May 2010

Article Tools

* Image Usage & Resolution